Potential application of biomimetic exosomes in cardiovascular disease: focused on ischemic heart disease

In Sook Kang, Kihwan Kwon

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Cardiovascular disease, especially ischemic heart disease, is a major cause of mortality worldwide. Cardiac repair is one of the most promising strategies to address advanced cardiovascular diseases. Despite moderate improvement in heart function via stem cell therapy, there is no evidence of significant improvement in mortality and morbidity beyond standard therapy. The most salutary effect of stem cell therapy are attributed to the paracrine effects and the stem cell-derived exosomes are known as a major contributor. Hence, exosomes are emerging as a promising therapeutic agent and potent biomarkers of cardiovascular disease. Furthermore, they play a role as cellular cargo and facilitate intercellular communication. However, the clinical use of exosomes is hindered by the absence of a standard operating procedures for exosome isolation and characterization, problems related to yield, and heterogeneity. In addition, the successful clinical application of exosomes requires strategies to optimize cargo, improve targeted delivery, and reduce the elimination of exosomes. In this review, we discuss the basic concept of exosomes and stem cell-derived exosomes in cardiovascular disease, and introduce current efforts to overcome the limitations and maximize the benefit of exosomes including engineered biomimetic exosomes. [BMB Reports 2022; 55(1): 30-38]

Original languageEnglish
Pages (from-to)30-38
Number of pages9
JournalBMB Reports
Issue number1
StatePublished - 2022

Bibliographical note

Publisher Copyright:
© 2022 by the The Korean Society for Biochemistry and Molecular Biology


  • Biomimetics
  • Cardiovascular disease
  • Exosome
  • Extracellular vesicles
  • Regenerative medicine


Dive into the research topics of 'Potential application of biomimetic exosomes in cardiovascular disease: focused on ischemic heart disease'. Together they form a unique fingerprint.

Cite this